Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study

To clarify the frequency of hypoglycemia in patients with type 1 diabetes mellitus receiving dapagliflozin combination therapy to reduce their basal insulin dose. Sixty subjects were assigned to two groups according to their basal insulin-to-total daily dose (TDD) ratio: group A (basal insulin/TDD &...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamaguchi, Masahide, Yoshimura, Yuta, Nakajima, Hanako, Tanaka, Toru, Hasegawa, Goji, Ishii, Michiyo, Okada, Hiroshi, Mitsuhashi, Kazuteru, Kitagawa, Noriyuki, Okamura, Takuro, Hashimoto, Yoshitaka, Majima, Saori, Senmaru, Takafumi, Ushigome, Emi, Nakanishi, Naoko, Asano, Mai, Yamazaki, Masahiro, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519412/
https://www.ncbi.nlm.nih.gov/pubmed/36213793
http://dx.doi.org/10.3164/jcbn.22-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519412/
https://www.ncbi.nlm.nih.gov/pubmed/36213793
http://dx.doi.org/10.3164/jcbn.22-7

Ejemplares similares